title: Serum ethanolamine and hepatocyte proliferation in perinatal and partially hepatectomized rats.
abstract: It has been shown that the administration of ethanolamine (Etn) to partially hepatectomized rats enhances stimulation of DNA synthesis in regenerating hepatocytes. The present study aimed to test the hypothesis that the level of serum Etn in vivo may be regulated to control the growth of hepatocytes. Concentrations of serum Etn were determined in rats 1) of varying ages (from embryonic-19 (E-19) to 7-week-old), and 2) during regeneration following two-thirds hepatectomy (PH), to investigate whether serum Etn concentration correlates with the rate of proliferation of hepatocytes in growing animals or during regeneration. Serum Etn levels were 3 fold higher in E-19 fetuses and newborns than in adults, and were increased 2 fold 4 h after PH and remained high for at least 24 h. Results in both systems indicated a significant positive correlation between the rate of hepatocyte proliferation and serum Etn levels. Furthermore, Etn supplementation of 0.1 to 1 mmol immediately after PH promoted a significant weight gain and stimulated phosphatidylethanolamine (PE) and phosphatidylcholine (PC) synthesis in the regenerating liver. We also observed that whenever serum Etn levels were elevated, the metabolism of PE and PC in the liver changed dynamically, first by elevating the net synthesis of PE. Taken together, these results suggested that the levels of serum Etn might be regulated based on the physiological state of an animal, which consequently regulates the proliferation of hepatocytes.
authors.affiliation: Department of Nutritional Research, Food Science Institute, Meiji Dairies Corporation, 540 Naruda, Odawara 250-0862, Japan. HISAE_KUME@MEIJI-MILK.COM
authors.forename: Hisae
authors.initials: H
authors.lastname: Kume
authors.forename: Hajime
authors.initials: H
authors.lastname: Sasaki
authors.forename: Tamiko
authors.initials: T
authors.lastname: Kano-Sueoka
mesh_terms: D000818:Animals; D049109:Cell Proliferation; D019856:Ethanolamine / Q000008:administration & dosage / Q000097:blood*; D005260:Female; D006498:Hepatectomy; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D008099:Liver / Q000737:chemistry; D008115:Liver Regeneration; D033261:Maternal-Fetal Relations; D010713:Phosphatidylcholines / Q000032:analysis / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000378:metabolism; D010743:Phospholipids / Q000032:analysis / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D015430:Weight Gain / Q000187:drug effects
chemical_list: D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010743:Phospholipids; C483858:phosphatidylethanolamine; D019856:Ethanolamine